Am. J. Respir. Crit. Care Med., Volume 161, Number 4, April 2000, 1294-1299

Detection of Granulocyte-Macrophage Colony-Stimulating Factor in Patients with Pulmonary Alveolar Proteinosis

MARTHA SUE CARRAWAY, ANDREW J. GHIO, JACQUELINE D. CARTER, and CLAUDE A. PIANTADOSI

Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Durham; and Division of Human Studies, Environmental Protection Agency, Chapel Hill, North Carolina

Pulmonary alveolar proteinosis (PAP) is an idiopathic lung disease in which the alveolar spaces are filled with surfactant. Recently, it has been proposed that PAP is caused by deficiency of granulocyte-macrophage colony-stimulating factor (GM-CSF) because GM-CSF-knockout mice develop the disease. To examine this possibility, we tested the two hypotheses that lung GM-CSF levels are low and that alveolar macrophages (AM) do not respond to GM-CSF in patients with PAP. Data from 10 adult patients with PAP who underwent therapeutic whole-lung lavage were compared with those of 10 healthy volunteers who underwent bronchoalveolar lavage (BAL) by fiberoptic bronchoscopy. Bronchoalveolar lavage fluid (BALF) and plasma were collected and analyzed for total protein and levels of GM-CSF, interleukin-3, and tumor necrosis factor (TNF)-. Isolated AM were cultured with or without lipopolysaccharide (LPS) or GM-CSF, and production of GM-CSF and TNF- was measured after 24 h. GM-CSF in BALF and plasma was higher in PAP than in control subjects (p  0.05), and was detectable under both reducing and nonreducing conditions as a 28-kD protein in BALF from the PAP patients. GM-CSF release by unstimulated AM from PAP patients was higher than in cells from control subjects, but the responses to LPS were similar. Mean TNF- release by AM in response to GM-CSF was higher in control subjects than in PAP patients due to a low response in three patients. In conclusion, unbound immunoreactive GM-CSF is detectable in BALF and plasma of PAP patients. Most PAP patients also had intact AM responses to GM-CSF, although some may have had defects in GM-CSF receptor or signal-transduction mechanisms. Although these data exclude lack of GM-CSF production as a common etiology of human PAP, defects in GM-CSF function in PAP are under investigation.

This article has been cited by other articles:

				Y. Inoue, B. C. Trapnell, R. Tazawa, T. Arai, T. Takada, N. Hizawa, Y. Kasahara, K. Tatsumi, M. Hojo, T. Ichiwata, et al. Characteristics of a Large Cohort of Patients with Autoimmune Pulmonary Alveolar Proteinosis in Japan Am. J. Respir. Crit. Care Med., April 1, 2008; 177(7): 752 - 762. [Abstract] [Full Text] [PDF]

				O C Ioachimescu and M S Kavuru Pulmonary alveolar proteinosis Chronic Respiratory Disease, July 1, 2006; 3(3): 149 - 159. [Abstract] [PDF]

				F-C Lin, G-D Chang, M-S Chern, Y-C Chen, and S-C Chang Clinical significance of anti-GM-CSF antibodies in idiopathic pulmonary alveolar proteinosis Thorax, June 1, 2006; 61(6): 528 - 534. [Abstract] [Full Text] [PDF]

				G. L. Snider Only Cell and Molecular Biology Can Lead to an Understanding of Pathogenesis of Lung Disease Am. J. Respir. Crit. Care Med., July 1, 2004; 170(1): i - ii. [Full Text]

				A. Perez IV and R. M. Rogers Enhanced Alveolar Clearance With Chest Percussion Therapy and Positional Changes During Whole-Lung Lavage for Alveolar Proteinosis Chest, June 1, 2004; 125(6): 2351 - 2356. [Abstract] [Full Text] [PDF]

				K. Uchida, K. Nakata, B. C. Trapnell, T. Terakawa, E. Hamano, A. Mikami, I. Matsushita, J. F. Seymour, M. Oh-eda, I. Ishige, et al. High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis Blood, February 1, 2004; 103(3): 1089 - 1098. [Abstract] [Full Text] [PDF]

				B. C. Trapnell, J. A. Whitsett, and K. Nakata Pulmonary Alveolar Proteinosis N. Engl. J. Med., December 25, 2003; 349(26): 2527 - 2539. [Full Text] [PDF]

				J. F. Seymour and J. J. Presneill Pulmonary Alveolar Proteinosis: Progress in the First 44 Years Am. J. Respir. Crit. Care Med., July 15, 2002; 166(2): 215 - 235. [Abstract] [Full Text] [PDF]

				M. J. TOBIN Tuberculosis, Lung Infections, and Interstitial Lung Disease in AJRCCM 2000 Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1774 - 1788. [Full Text] [PDF]

				M. S. Carraway, C. A. Piantadosi, and J. R. Wright Alveolar proteinosis: a disease of mice and men Am J Physiol Lung Cell Mol Physiol, March 1, 2001; 280(3): L377 - L378. [Full Text] [PDF]